225 related articles for article (PubMed ID: 31974566)
1. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
Lee EQ; Weller M; Sul J; Bagley SJ; Sahebjam S; van den Bent M; Ahluwalia M; Campian JL; Galanis E; Gilbert MR; Holdhoff M; Lesser GJ; Lieberman FS; Mehta MP; Penas-Prado M; Schreck KC; Strowd RE; Vogelbaum MA; Walbert T; Chang SM; Nabors LB; Grossman S; Reardon DA; Wen PY
Neuro Oncol; 2020 May; 22(5):601-612. PubMed ID: 31974566
[TBL] [Abstract][Full Text] [Related]
2. Barriers to accrual and enrollment in brain tumor trials.
Lee EQ; Chukwueke UN; Hervey-Jumper SL; de Groot JF; Leone JP; Armstrong TS; Chang SM; Arons D; Oliver K; Verble K; Musella A; Willmarth N; Alexander BM; Bates A; Doherty L; Galanis E; Gaffey S; Halkin T; Friday BE; Fouladi M; Lin NU; Macdonald D; Mehta MP; Penas-Prado M; Vogelbaum MA; Sahebjam S; Sandak D; van den Bent M; Weller M; Reardon DA; Wen PY
Neuro Oncol; 2019 Sep; 21(9):1100-1117. PubMed ID: 31175826
[TBL] [Abstract][Full Text] [Related]
3. Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
Rogers JL; Acquaye A; Vera E; Bates A; Wen PY; Armstrong TS
Neurooncol Pract; 2020 Jan; 7(1):38-51. PubMed ID: 32257283
[TBL] [Abstract][Full Text] [Related]
4. Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research.
Ebrahimi H; Castro DV; Feng MI; Prajapati SR; Lee KO; Chan EH; Paul T; Sehgal I; Patel J; Li X; Zengin ZB; Meza L; Mercier BD; Hsu J; Govindarajan A; Chawla N; Dizman N; Bergerot CD; Rock A; Liu S; Tripathi A; Dorff T; Pal SK; Chehrazi-Raffle A
Clin Genitourin Cancer; 2023 Dec; 21(6):e467-e473. PubMed ID: 37301665
[TBL] [Abstract][Full Text] [Related]
5. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
Kim ES; Bruinooge SS; Roberts S; Ison G; Lin NU; Gore L; Uldrick TS; Lichtman SM; Roach N; Beaver JA; Sridhara R; Hesketh PJ; Denicoff AM; Garrett-Mayer E; Rubin E; Multani P; Prowell TM; Schenkel C; Kozak M; Allen J; Sigal E; Schilsky RL
J Clin Oncol; 2017 Nov; 35(33):3737-3744. PubMed ID: 28968170
[TBL] [Abstract][Full Text] [Related]
6. Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application.
Kim ES; Atlas J; Ison G; Ersek JL
Am Soc Clin Oncol Educ Book; 2016; 35():83-90. PubMed ID: 27249689
[TBL] [Abstract][Full Text] [Related]
7. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
[TBL] [Abstract][Full Text] [Related]
8. Accrual of older adults to cancer clinical trials led by the Canadian cancer trials group - Is trial design a barrier?
Hernandez-Torres C; Cheung WY; Kong S; O'Callaghan CJ; Hsu T
J Geriatr Oncol; 2020 Apr; 11(3):455-462. PubMed ID: 31473189
[TBL] [Abstract][Full Text] [Related]
9. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.
Spira AI; Stewart MD; Jones S; Chang E; Fielding A; Richie N; Wood LS; Thompson MA; Jones L; Nair A; Mahal BA; Gerber DE
Clin Cancer Res; 2021 May; 27(9):2416-2423. PubMed ID: 33563636
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
Alexander BM; Brown PD; Ahluwalia MS; Aoyama H; Baumert BG; Chang SM; Gaspar LE; Kalkanis SN; Macdonald DR; Mehta MP; Soffietti R; Suh JH; van den Bent MJ; Vogelbaum MA; Wefel JS; Lee EQ; Wen PY;
Lancet Oncol; 2018 Jan; 19(1):e33-e42. PubMed ID: 29304360
[TBL] [Abstract][Full Text] [Related]
11. A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria.
Gerber DE; Singh H; Larkins E; Ferris A; Forde PM; Selig W; Basu Roy U
JAMA Oncol; 2022 Sep; 8(9):1333-1339. PubMed ID: 35925576
[TBL] [Abstract][Full Text] [Related]
12. Involving South Asian patients in clinical trials.
Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
[TBL] [Abstract][Full Text] [Related]
13. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.
Lin NU; Prowell T; Tan AR; Kozak M; Rosen O; Amiri-Kordestani L; White J; Sul J; Perkins L; Beal K; Gaynor R; Kim ES
J Clin Oncol; 2017 Nov; 35(33):3760-3773. PubMed ID: 28968165
[TBL] [Abstract][Full Text] [Related]
14. How to improve accrual to clinical trials of symptom control 2: design issues.
Vickers AJ
J Soc Integr Oncol; 2007; 5(2):61-4. PubMed ID: 17511931
[TBL] [Abstract][Full Text] [Related]
15. Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
Budhu JA; Chukwueke UN; Jackson S; Lee EQ; McFaline-Figueroa JR; Willmarth N; Dalmage M; Kawachi I; Arons D; Chang SM; Galanis E; Hervey-Jumper SL; Wen PY; Porter AB
Neuro Oncol; 2024 Apr; 26(4):596-608. PubMed ID: 38071654
[TBL] [Abstract][Full Text] [Related]
16. Clinical Trial Considerations in Neuro-oncology.
Lee EQ
Curr Treat Options Oncol; 2021 Jul; 22(9):78. PubMed ID: 34213625
[TBL] [Abstract][Full Text] [Related]
17. Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015.
Jin S; Pazdur R; Sridhara R
J Clin Oncol; 2017 Nov; 35(33):3745-3752. PubMed ID: 28968168
[TBL] [Abstract][Full Text] [Related]
18. Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials.
Peterson JS; Plana D; Bitterman DS; Johnson SB; Aerts HJWL; Kann BH
Cancer Med; 2023 Feb; 12(4):4715-4724. PubMed ID: 36398619
[TBL] [Abstract][Full Text] [Related]
19. Reducing patient eligibility criteria in cancer clinical trials.
George SL
J Clin Oncol; 1996 Apr; 14(4):1364-70. PubMed ID: 8648395
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
